Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-05-06
DOI
10.3389/fgene.2015.00168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells
- (2015) Kiren Yacqub-Usman et al. PROSTATE
- Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy
- (2014) Mark R. Pickard et al. BREAST CANCER RESEARCH AND TREATMENT
- Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes
- (2014) Ugur Gezer et al. CELL BIOLOGY INTERNATIONAL
- Investigation of circulating lncRNAs in B-cell neoplasms
- (2014) Mustafa Isin et al. CLINICA CHIMICA ACTA
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- LincRNA-p21 Activates p21 In cis to Promote Polycomb Target Gene Expression and to Enforce the G1/S Checkpoint
- (2014) Nadya Dimitrova et al. MOLECULAR CELL
- LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
- (2014) GUANGYU WANG et al. ONCOLOGY REPORTS
- Systematic Review of Complications of Prostate Biopsy
- (2013) Stacy Loeb et al. EUROPEAN UROLOGY
- Comparative Effectiveness Review: Prostate Cancer Antigen 3 Testing for the Diagnosis and Management of Prostate Cancer
- (2013) Linda A. Bradley et al. JOURNAL OF UROLOGY
- Prostate Cancer Biomarker Profiles in Urinary Sediments and Exosomes
- (2013) Siebren Dijkstra et al. JOURNAL OF UROLOGY
- VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer
- (2013) Georges St Laurent et al. GENOME BIOLOGY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life
- (2012) Brooke L. Deatherage et al. INFECTION AND IMMUNITY
- Exosomes: New players in cell–cell communication
- (2012) Claudia Bang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA
- (2011) Philipp Kapranov et al. BMC BIOLOGY
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer
- (2011) M. J. Friedrich JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions
- (2011) Alexandre de la Taille et al. JOURNAL OF UROLOGY
- Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
- (2011) Fulya Yaman Agaoglu et al. TUMOR BIOLOGY
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance
- (2010) Guillaume Ploussard et al. EUROPEAN UROLOGY
- What Happens After an Elevated PSA Test: The Experience of 13,591 Veterans
- (2010) Steven B. Zeliadt et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Efficacy vs Effectiveness in Prostate-Specific Antigen Screening
- (2010) P. C. Albertsen JNCI-Journal of the National Cancer Institute
- Noncoding RNA Gas5 Is a Growth Arrest- and Starvation-Associated Repressor of the Glucocorticoid Receptor
- (2010) T. Kino et al. Science Signaling
- Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia
- (2010) Juan Morote et al. WORLD JOURNAL OF UROLOGY
- Prostate-specific antigen-based screening for prostate cancer in the third millennium: Useful or hype?
- (2009) Giuseppe Lippi et al. ANNALS OF MEDICINE
- Other biomarkers for detecting prostate cancer
- (2009) Lucas Nogueira et al. BJU INTERNATIONAL
- An Update of the Gleason Grading System
- (2009) Jonathan I. Epstein JOURNAL OF UROLOGY
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
- (2009) Ahmad M. Khalil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men
- (2008) Felix K.-H. Chun et al. CANCER
- PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
- (2008) Hiroyuki Nakanishi et al. JOURNAL OF UROLOGY
- Proteomic profiling of exosomes: Current perspectives
- (2008) Richard J. Simpson et al. PROTEOMICS
- Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
- (2007) Claudio Jeldres et al. EUROPEAN UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started